Clin2
NCT07509307Possibly a fitRecruiting

Study of a new medicine for weight loss and knee pain in osteoarthritis

ObesityOverweightOsteoarthritis, Knee

Treatments studied

Part of Bones, joints & muscles, Hormones & metabolism clinical trials.

This trial tests if a new medicine, NNC0487-0111, can help people with excess weight and knee osteoarthritis lose weight and reduce knee pain. It is for people who have had knee pain for at least three months and who can stop taking pain relievers for short periods before study visits.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
400 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been diagnosed with knee osteoarthritis and have x-ray changes in your most painful knee
  • You have had knee pain for more than 90 days and had pain on more than 15 of the last 30 days
  • You are willing to stop taking pain relievers for 72 hours before some visits (acetaminophen is allowed up to 24 hours before)
  • You do not have diabetes or a blood sugar level above a certain threshold
  • You have not taken certain weight-loss medicines (GLP-1 or similar drugs) before

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07481630Recruiting· Phase 3
Testing a new medicine for weight loss and knee pain

This study tests if a new medicine called NNC0487-0111 can help people with extra weight and knee osteoarthritis lose weight and reduce knee pain. If you have knee pain most days and are willing to stop pain relievers for short periods, you may be able to join.

Phoenix, Arizona
NCT06833749Recruiting· Phase 2
Testing KBP-336 for knee osteoarthritis with obesity

This study tests an experimental medicine called KBP-336 for people with both obesity and knee osteoarthritis who still have significant knee pain despite standard treatments. It aims to see if KBP-336 can reduce pain and improve function.

Brno
NCT07339423Recruiting· Phase 3
A study of a new medicine for weight loss

This study tests a new medicine to see how well it helps people with excess body weight lose weight. It may be an option if you have tried to lose weight through dieting before but haven't had lasting success.

Miramar, Florida
NCT07734311Not yet recruiting· Phase 3
Testing a weight-loss injection for knee arthritis pain

This study tests whether an experimental weight-loss injection can reduce knee pain in people who are obese and have knee osteoarthritis. It may help if you have been unable to lose weight through diet and exercise and have moderate knee pain.

Wuhan, Hubei
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.